BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22670709)

  • 1. Activation of AMPK by pterostilbene suppresses lipogenesis and cell-cycle progression in p53 positive and negative human prostate cancer cells.
    Lin VC; Tsai YC; Lin JN; Fan LL; Pan MH; Ho CT; Wu JY; Way TD
    J Agric Food Chem; 2012 Jun; 60(25):6399-407. PubMed ID: 22670709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
    Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
    Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells.
    Pan MH; Chang YH; Badmaev V; Nagabhushanam K; Ho CT
    J Agric Food Chem; 2007 Sep; 55(19):7777-85. PubMed ID: 17696482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
    Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
    O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
    Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene.
    Lee H; Kim Y; Jeong JH; Ryu JH; Kim WY
    PLoS One; 2016; 11(9):e0162335. PubMed ID: 27612029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of calcium-independent phospholipase A2 activates p38 MAPK signaling pathways during cytostasis in prostate cancer cells.
    Sun B; Zhang X; Yonz C; Cummings BS
    Biochem Pharmacol; 2010 Jun; 79(12):1727-35. PubMed ID: 20171194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein.
    Hsu JC; Dev A; Wing A; Brew CT; Bjeldanes LF; Firestone GL
    Biochem Pharmacol; 2006 Dec; 72(12):1714-23. PubMed ID: 16970927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.
    Roy S; Packman K; Jeffrey R; Tenniswood M
    Cell Death Differ; 2005 May; 12(5):482-91. PubMed ID: 15746940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway.
    Yi G; He Z; Zhou X; Xian L; Yuan T; Jia X; Hong J; He L; Liu J
    Int J Oncol; 2013 Nov; 43(5):1503-10. PubMed ID: 23982736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological/chemopreventive activity of stilbenes and their effect on colon cancer.
    Rimando AM; Suh N
    Planta Med; 2008 Oct; 74(13):1635-43. PubMed ID: 18843589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
    Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
    Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
    Won SH; Lee HJ; Jeong SJ; Lü J; Kim SH
    Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells.
    Loubière C; Goiran T; Laurent K; Djabari Z; Tanti JF; Bost F
    Oncotarget; 2015 Jun; 6(17):15652-61. PubMed ID: 26002551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemopreventive effects of pterostilbene through p53 and cell cycle in mouse lung of squamous cell carcinoma model.
    Surien O; Ghazali AR; Masre SF
    Sci Rep; 2021 Jul; 11(1):14862. PubMed ID: 34290382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
    Katkoori VR; Manne K; Vital-Reyes VS; Rodríguez-Burford C; Shanmugam C; Sthanam M; Manne U; Chatla C; Abdulkadir SA; Grizzle WE
    Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
    Choi MS; Oh JH; Kim SM; Jung HY; Yoo HS; Lee YM; Moon DC; Han SB; Hong JT
    Int J Oncol; 2009 May; 34(5):1221-30. PubMed ID: 19360335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
    Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
    Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.